celastrol has been researched along with Lung Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, X; Cheng, C; Huang, S; Lei, Y; Li, Z; Luo, H; Tang, Y; Zou, X | 1 |
| Chen, W; Hao, RM; Li, YJ; Ma, X; Ma, Y; Sun, YX; Wang, PY; Wu, P; Xie, N; Xie, SY; Zhang, LJ | 1 |
2 other study(ies) available for celastrol and Lung Adenocarcinoma
| Article | Year |
|---|---|
Pristimerin Exacerbates Cellular Injury in Conditionally Reprogrammed Patient-Derived Lung Adenocarcinoma Cells by Aggravating Mitochondrial Impairment and Endoplasmic Reticulum Stress through EphB4/CDC42/N-WASP Signaling.
Topics: Adenocarcinoma of Lung; Cell Movement; Cell Proliferation; Endoplasmic Reticulum Stress; Humans; Mitochondria; Pentacyclic Triterpenes; Signal Transduction; Transfection; Tripterygium | 2020 |
miR-33a-5p enhances the sensitivity of lung adenocarcinoma cells to celastrol by regulating mTOR signaling.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Animals; Apoptosis; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; MicroRNAs; Middle Aged; Pentacyclic Triterpenes; Signal Transduction; TOR Serine-Threonine Kinases; Triterpenes; Xenograft Model Antitumor Assays | 2018 |